|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | History of the infantile hepatic hemangioma:From imaging to generating a differential diagnosis显示文摘We aim to provide an up-to-date summary of infantile hepatic hemangioma(IHH) and its misnomers and to dialectically present the differential diagnosis of these rare entities of the liver.Eligible peer-reviewed articles on hepatic infantile hemangiomas,published between 2000 and 2015,were reviewed for this study.IHH is the most common hepatic vascular tumor in children.Once a liver mass is identified in an infant,the differential diagnosis ranges from vascular malformations to benign and malignant tumors including mesenchymal hamartoma,hepatoblastoma,metastatic neuroblastoma,so careful physical examination,imaging studies,and,if indicated,tumor markers and biopsy,are of pivotal importance to ascertain the correct diagnosis.Despite the benign nature of IHHs,some of these lesions may demand medical and/or surgical intervention,especially for multiple and diffuse IHH.Complications can include hepatomegaly,hypothyroidism and cardiac failure.Therefore,a close follow-up is required until complete involution of the lesions.We propose an algorithm to guide the physicians towards the proper management of hepatic lesions. | Maria Gnarra Gerald Behr Alison Kitajewski June K Wu Sudha A Anupindi Carrie J Shawber Nick Zavras Dimitrios Schizas Chris Salakos Konstantinos P Economopoulos | 2016 | World Journal of Clinical Pediatrics2016，5，3： | 27 |
| 2 | Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease显示文摘Nonalcoholic fatty liver disease(NAFLD) is the most common chronic liver disease in the United States and represents an increasingly important etiology of hepatocellular carcinoma(HCC) with annual cumulative incidence rates ranging from 2% to 12% in cohorts of NAFLD cirrhosis. While the risk of progression of NAFLD to HCC remains higher among patients with fibrosis or cirrhosis, an increasing amount of literature describes NAFLD-HCC as a disease that can occur in the absence of cirrhosis. Efforts to characterize the pathogenesis of NAFLD-HCC have suggested mechanisms that strongly associate with states of hyperinsulinemia and chronic inflammation, cellular mechanisms including adaptive immune responses and hepatic progenitor cell populations, and genetic polymorphisms including mutations of PNPLA3. Current literature describes NAFLD-HCC mostly as a disease of late presentation with lower rates of receipt of curative therapy and worse prognosis. However, a growing body of evidence has reported comparable and potentially more favorable disease-free and overall survival rates among patients with NAFLD-HCC after receipt of curative treatment. This review summarizes current evidence of epidemiology, pathophysiology, disease presentation, demand and receipt of curative therapy, post-treatment outcomes, and overall survival of NAFLD-associated HCC. | Carrie R Wong Mindie H Nguyen Joseph K Lim | 2016 | World Journal of Gastroenterology2016，22，37： | 5 |
| 3 | 风险沟通概要显示文摘1 引言
全球制药公司和卫生当局共同的首要目标即保护患者的用药安全。为了实现这一目标,制药公司和卫生当局不断寻求更新、更好的方式,以确保药品正确用于适用人群,并最大限度降低药品不良反应发生的风险。药物警戒不仅加强了传统的回顾性监测,即对从产品研发期间到上市后发生的不良事件做出反应,也增加了前瞻性职能(即试图预测用药风险并避免其发生)。上述监测中,须制定计划以解决从信息中获取到的问题。该计划通常应包括如何采取有效途径将药品的新的风险传达给潜在的广泛人群。 | Carrie E Corboy Janice K Bush 无 | 2009 | 中国药物警戒2009，6，7： | 2 |
| 4 | Delamination resistant laminates by Z-fiber pinning Ⅰ: Manufacture and fracture performance 显示文摘 | Partridge I K Carrie D D R | 2005 | Composites Part A2005，36，1： | 1 |
| 5 | PUFA for prevention and treatment of dementia? 显示文摘 | CARRIE I ABELLAN V K G ROLLAND Y | 2009 | Curt Pharm Des2009，15，36： | 1 |
| 6 | Multiscale aspects of the influence of yttrium on microstructure, sintering and creep of alumina 显示文摘 | Lartigue K S Carry C Prieeter L | 2002 | Journal of the Europe Ceramic Society2002，，22： | 1 |
| 7 | A-type granites:Geochemical characteristics, discrimination and petrogenesis 显示文摘 | Whalen J B Carrie K L Chappell B W | 1987 | Contrib Mineral Petrol1987，95，： | 1 |
| 8 | Angiographic embohsation in the management of pelvic haemnrrhage 显示文摘 | Lingam K Hood V Carry M J | 2000 | B JOG2000，107，9： | 1 |
| 9 | Phytochemical study of a potential anti-tubercular Tibetan medicinal plant, C, entianopsis paludosa显示文摘 | Yeung M F Carrie K W Yeung A | 2009 | Natura Proda Medica2009，2，： | 1 |
| 10 | 3D reinforcement of stiffener-to skin T-joints by z pinning and tufting 显示文摘 | Carrie D D R Dell'Anno G Poulin E Partridge I K | 2006 | Engineering Fracture Mechanics2006，73，： | 1 |
| 11 | Sorption of inorganic and total phosphorus from dairy and swine slurries to soil显示文摘 | Marshall Sarah K Laboski Carrie A M | 2006 | Environ Qual2006，35，： | 1 |
| 12 | 3D reinforcement of stiffener-to-skin T-joints by Z-pinning and tufting显示文摘 | Denis D R Carrie Giuseppe Dell Anno Emilie Poulin Ivana K Partridge | 2006 | Engineering Fracture Mechanics2006，73，16： | 1 |
| 13 | Variation in the use of skull ra-diographs by emergency physicians in young children with mi- nor head trauma显示文摘 | Carri~re B C16ment K Gravel J | 2014 | CJEM2014，16，4： | 1 |
| 14 | THP-1 cell apoptosis in response to mycobacterial infection 显示文摘 | Carrie JR Hardy K | 2003 | Infection and Immunity2003，71，1： | 1 |
| 15 | Impact of conditioning regimen on peripheral blood hematopoietic cell transplant显示文摘AIM To investigate infused hematopoietic cell doses and their interaction with conditioning regimen intensity +/-total body irradiation(TBI) on outcomes after peripheral blood hematopoietic cell transplant(PBHCT).METHODS Our retrospective cohort included 247 patients receiving a first, T-replete, human leukocyte antigen-matched allogeneic PBHCT and treated between 2001 and2012. Correlations were calculated using the Pearson product-moment correlation coefficient. Overall survival and progression free survival curves were generated using the Kaplan-Meier method and compared using the log-rank test.RESULTS Neutrophil engraftment was significantly faster after reduced intensity TBI based conditioning [reduced intensity conditioning(RIC) + TBI] and > 4 × 10~6 CD34+cells/kg infused. A higher total nucleated cell dose led to a higher incidence of grade II-IV acute graft-versus-host disease in the myeloablative + TBI regimen group(P = 0.03), but no significant difference in grade III-IV graft-versus-host disease. A higher total nucleated cell dose was also associated with increased incidence of moderate/severe chronic graft-versus-host disease, regardless ofconditioning regimen. Overall and progression-free survival were significantly better in patients with a RIC + TBI regimen and total nucleated cell dose > 8 ×10~8/kg(3 years, overall survival: 70% vs 38%, P = 0.02, 3 years, progression free survival: 64% vs 38%, P = 0.02).CONCLUSION TBI and conditioning intensity may alter the relationship between infused cell doses and outcomes after PBHCT. Immune cell subsets may predict improved survival after unmanipulated PBHCT. | Michael Burns Anurag K Singh Carrie C Hoefer Yali Zhang Paul K Wallace George L Chen Alexis Platek Timothy B Winslow Austin J Iovoli Christopher Choi Maureen Ross Philip L McCarthy Theresa Hahn | 2019 | World Journal of Clinical Oncology2019，10，2： | 1 |
| 16 | Surgical versus nonsurgi cal treatment of empyema thoracis显示文摘 | Mapk P Carrie K Edward R | 2003 | Am J Med Sci2003，326，1： | 1 |
| 17 | Alterations in body composition and spasticity following subtetanic neu- romuscular electrical stimulation training in spinal cord injury 显示文摘 | Carry A McCormack K Coughlan GF | 2013 | J Rehabil Res Dev2013，50，2： | 1 |
| 18 | A continuous lcord dvegetation and climate change over the past 50, 000 years in the Fujian Province of eastern subtropical China显示文摘 | YUE Y ZHENG Z HUANG K CHEVALIER M CHASE M B CARRI M LEDRU M P CHEDDADI R | 2012 | Palaeogeography Palaeoclimatology Palaeoecology2012，，： | 1 |
| 19 | A type granites: Geochemical characteristics, discrimination and petrogenesis 显示文摘 | Whalen J B Carrie K L ChappeU B W | 1987 | Contribution to Mineralogy and Petrology1987，95，： | 1 |
| 20 | Eosinophil apoptosis and resolution of airway inflammation in asthma 显示文摘 | Woolley KL Gibson PG Carry K | 1996 | Am J Respir Crit Care Med1996，154，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员